Plains Ventures

Cadenza Bio is a biotechnology company focused on developing highly selective small-molecule drugs aimed at treating demyelinating and inflammatory diseases. The company is dedicated to creating therapeutic medications that not only alleviate symptoms but also halt disease progression, promote repair, and enhance the quality of life for patients. By prioritizing the development of innovative treatments, Cadenza Bio aims to empower patients to regain control over their health and improve their overall well-being.

DEKA Biosciences is an early-stage biotechnology company focused on developing next-generation cytokine therapeutics aimed at treating cancer and inflammatory diseases. The company creates therapies with disease-specific applications that enhance patient outcomes by optimizing pharmacokinetics and pharmacodynamics through the targeted delivery of dual and complementary cytokines to affected tissues or cells. This innovative approach seeks to provide patients with curative treatment options for various conditions, including cancer, autoimmune disorders, and infectious diseases.

PatchRx is a remote therapeutic management platform focused on enhancing medication adherence and patient compliance. The company offers a comprehensive solution that includes a universal smart pill bottle, a patient-facing app, and a web app. This system aids patients in taking their medications on schedule, facilitates refill requests, and incentivizes adherence through rewards. Additionally, PatchRx provides healthcare providers with real-time adherence data, enabling them to better support their patients. By leveraging data-driven technology, PatchRx aims to improve health outcomes and streamline the management of medication compliance.

Wheeler Bio is a biomanufacturing company founded in 2020 by Jesse McCool in Oklahoma City, focused on accelerating the translation of therapeutic innovations into clinical applications. The company offers a unique platform that integrates pre-clinical discovery with biomanufacturing processes, addressing critical gaps that often hinder the development of new therapies. By providing access to comprehensive discovery-to-IND programs, Wheeler Bio enables biopharma companies to streamline their path to clinical trials. Its Portable CMC platform ensures rapid and high-quality biomanufacturing, allowing clients to achieve a predictable and efficient route to bringing therapies to market.

Access Optics specializes in the manufacturing of precision and micro-scale optics tailored for applications in medical equipment and advanced imaging systems. The company integrates innovative manufacturing engineering, process development, and optical fabrication with cutting-edge coating technology. Its product offerings include optical assemblies, micro-scale surgical imaging products, and hermetic seals specifically designed to withstand extreme pressures, temperatures, and humidity levels. These advanced solutions are particularly beneficial for leading original equipment manufacturers in fields such as endoscopy, dermatology, aerospace, and chromatography, ultimately enhancing surgical outcomes and enabling breakthrough developments in various industries.